English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 27 Help

Selected(0)Clear Items/Page:    Sort:
GSH/pH Dual Activatable Crosslinked and Fluorinated PEI for Cancer Gene Therapy through Endogenous Iron De-Hijacking and in situ ROS Amplification Journal article
Chen MW(陳美婉). GSH/pH Dual Activatable Crosslinked and Fluorinated PEI for Cancer Gene Therapy through Endogenous Iron De-Hijacking and in situ ROS Amplification[J]. ADVANCED MATERIALS, 2023.
Authors:  Chen MW(陳美婉)
Favorite |   IF:27.4/30.2 | Submit date：2023/08/21
Non-apoptotic cell death-based cancer therapy: molecular mechanism, pharmacological modulators, and nanomedicine Journal article
Chen MW(陳美婉). Non-apoptotic cell death-based cancer therapy: molecular mechanism, pharmacological modulators, and nanomedicine[J]. Acta Pharmaceutica Sinica B, 2022.
Authors:  Chen MW(陳美婉)
Favorite |   IF:14.7/14.1 | Submit date：2023/08/23
Development of Nanoscale Drug Delivery Systems of Dihydroartemisinin for Cancer Therapy: A Review Journal article
Chen MW(陳美婉). Development of Nanoscale Drug Delivery Systems of Dihydroartemisinin for Cancer Therapy: A Review[J]. Asian Journal of Pharmaceutical Sciences, 2022.
Authors:  Chen MW(陳美婉)
Favorite |   IF:10.7/9.0 | Submit date：2023/08/21
Pharmacological activities and molecular mechanisms of Pulsatilla saponins Journal article
Chen MW(陳美婉). Pharmacological activities and molecular mechanisms of Pulsatilla saponins[J]. Chinese Medicine, 2022.
Authors:  Chen MW(陳美婉)
Favorite |   IF:5.3/5.5 | Submit date：2023/08/21
A Simple Method for Peak Alignment Using Relative Retention Time Related to an Inherent Peak in Liquid Chromatography-Mass Spectrometry-Based Metabolomics Journal article
Wang Y., Ma L., Zhang M., Chen, MW, Li P., He C., Yan C., Wan J.-B.. A Simple Method for Peak Alignment Using Relative Retention Time Related to an Inherent Peak in Liquid Chromatography-Mass Spectrometry-Based Metabolomics[J]. Journal of chromatographic science, 2019, 57(1), 9-16.
Authors:  Wang Y.;  Ma L.;  Zhang M.;  Chen, MW;  Li P.; et al.
Favorite | TC[WOS]:13 TC[Scopus]:12  IF:1.5/1.6 | Submit date：2018/12/28
Novel nanoparticulate drug delivery systems for active ingredients of traditional Chinese medicine in cancer therapy Book chapter
出自: Pharmaceutical Dosage Forms and Drug Delivery, Boca Raton:CRC Press, 2017
Authors:  MW Chen;  ZP Guo
Favorite |  | Submit date：2019/01/10
Preparation, Characterization, and Antitumor Efficacy of Evodiamine Loaded PLGA Nanoparticles Journal article
Zhou, LD, Chen, FQ, Bao, JL, Wang, SP, Wang, L, Chen, MW, He, C. W., Wang, Y. T.. Preparation, Characterization, and Antitumor Efficacy of Evodiamine Loaded PLGA Nanoparticles[J]. Drug Delivery, 2016, 898-906.
Authors:  Zhou, LD;  Chen, FQ;  Bao, JL;  Wang, SP;  Wang, L; et al.
Favorite | TC[WOS]:30 TC[Scopus]:29  IF:6.5/6.7 | Submit date：2022/07/28
Anticancer Activity  Plga Nanoparticles  Breast Cancer  Evodiamine  Formulation  
Nucleolin targeting AS1411 aptamer modified pH-sensitive micelles: A dual-functional strategy for paclitaxel delivery Journal article
Zhang JM, Chen RE, Chen FQ, Chen MW, Wang YT. Nucleolin targeting AS1411 aptamer modified pH-sensitive micelles: A dual-functional strategy for paclitaxel delivery[J]. Journal of Controlled Release, 2015, 213, E137-E138.
Authors:  Zhang JM;  Chen RE;  Chen FQ;  Chen MW;  Wang YT
Favorite | TC[WOS]:20 TC[Scopus]:0  IF:10.5/10.6 | Submit date：2018/11/27
Active Targeting  Ph-sensitive  As1411 Aptamar  Self-assembly  Anticancer  
Function of Nogo-A/Nogo-A Receptor in Alzheimer's Disease Journal article
Xu YQ, Sun ZQ, Wang YT, Xiao F, Chen MW. Function of Nogo-A/Nogo-A Receptor in Alzheimer's Disease[J]. CNS NEUROSCIENCE & THERAPEUTICS, 2015, 21(6), 479-485.
Authors:  Xu YQ;  Sun ZQ;  Wang YT;  Xiao F;  Chen MW
Favorite | TC[WOS]:20 TC[Scopus]:21  IF:4.8/5.9 | Submit date：2020/03/30
Alzheimer's Disease  Nogo-a Receptor  Nogo-a  
Nanoscale drug delivery for taxanes based on the mechanism of multidrug resistance of cancer Journal article
Wang SP, Qiu JG, Shi Z, Wang YT, Chen MW. Nanoscale drug delivery for taxanes based on the mechanism of multidrug resistance of cancer[J]. Biotechnology Advances, 2015, 33(1), 224-241.
Authors:  Wang SP;  Qiu JG;  Shi Z;  Wang YT;  Chen MW
Favorite | TC[WOS]:37 TC[Scopus]:37  IF:12.1/14.6 | Submit date：2018/11/27
Cancer  Multidrug Resistance  Nanoparticles  Taxanes